Form 4: Danaher Corp Executive Sells Shares After Exercising Options

Sentiment:

SEC Form 4 Filing


A Danaher Corp executive, Daniel Raskas, sold shares after exercising stock options, according to a recent SEC filing.

Summary

  • Daniel Raskas, a Senior Vice President at Danaher Corp, engaged in multiple transactions involving the company's common stock.
  • On November 25, 2024, Raskas sold 8,370 shares at a price of $238 per share.
  • On November 26, 2024, Raskas exercised options to acquire 26,318 shares at a price of $58.59 per share.
  • Following the option exercise, Raskas sold the 26,318 shares at a weighted average price of $236.587 per share.
  • After these transactions, Raskas directly owns 15,225 shares of Danaher Corp common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine transaction by an executive and does not indicate any positive or negative outlook for the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. These transactions are closely monitored by investors for insights into management's view of the company's prospects.

Comparison to Industry Standards

  • Executive stock option exercises and subsequent sales are a common practice across publicly traded companies, particularly in the technology and healthcare sectors where Danaher operates.
  • The vesting schedule of one-third of the options becoming exercisable on the third, fourth, and fifth anniversaries of the grant date is a typical vesting structure.
  • The price range of $236.515 to $236.700 for the sale of shares is consistent with the market price of Danaher stock at the time of the transaction.
  • Companies like Thermo Fisher Scientific (TMO) and Agilent Technologies (A) also have similar insider transaction filings, reflecting the standard practice of executive compensation and stock ownership.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders as they are routine insider sales.
  • The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
02/24/2016Grant date of the employee stock options, which vest over time.
11/25/2024Date of the first sale of 8,370 shares at $238 per share.
11/26/2024Date of option exercise and subsequent sale of 26,318 shares.
11/27/2024Date of the SEC filing.

Keywords

Danaher Corp, stock options, insider trading, SEC Form 4, equity securities, executive compensation, share sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.